BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19351569)

  • 21. Does prior aspirin use reduce stroke mortality?
    Karlikaya G; Varlbas F; Demirkaya M; Orken C; Tireli H
    Neurologist; 2006 Sep; 12(5):263-7. PubMed ID: 16990739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discharge medications among ischemic stroke survivors.
    Sweileh WM; Sawalha AF; Zyoud SH; Al-Jabi SW; Abaas MA
    J Stroke Cerebrovasc Dis; 2009; 18(2):97-102. PubMed ID: 19251184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients.
    Sztriha LK; Sas K; Seres E; Boda K; Lenti L; Csifcsak G; Kovacs N; Vecsei L
    Acta Neurol Scand; 2008 Apr; 117(4):250-4. PubMed ID: 17961197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Factors associated to aspirin failure for secondary stroke prevention].
    Chamorro A; Blanc R; Ascaso C; Saiz A; Vila N
    Med Clin (Barc); 1997 Nov; 109(15):569-72. PubMed ID: 9441190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.
    Kasner SE; Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Benesch CG; Sila CA; Jovin TG; Romano JG; Cloft HJ;
    Circulation; 2006 Jan; 113(4):555-63. PubMed ID: 16432056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke.
    Maulaz AB; Bezerra DC; Michel P; Bogousslavsky J
    Arch Neurol; 2005 Aug; 62(8):1217-20. PubMed ID: 16087761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke.
    Putaala J; Kurkinen M; Tarvos V; Salonen O; Kaste M; Tatlisumak T
    Neurology; 2009 May; 72(21):1823-9. PubMed ID: 19470964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of aspirin on lipoprotein(a) in patients with ischemic stroke.
    Ranga GS; Kalra OP; Tandon H; Gambhir JK; Mehrotra G
    J Stroke Cerebrovasc Dis; 2007; 16(5):220-4. PubMed ID: 17845920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Premorbid antiplatelet use and ischemic stroke outcomes.
    Sanossian N; Saver JL; Rajajee V; Selco SL; Kim D; Razinia T; Ovbiagele B
    Neurology; 2006 Feb; 66(3):319-23. PubMed ID: 16382033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of antiplatelet treatment with aspirin in polymorbid patients.
    Paluch Z; Jedlicková V; Skibova J; Adamek T; Alusík S
    Int Angiol; 2007 Sep; 26(3):206-12. PubMed ID: 17622200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality.
    Elkind MS; Flint AC; Sciacca RR; Sacco RL
    Neurology; 2005 Jul; 65(2):253-8. PubMed ID: 16043795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
    Park MK; Smith PC; Wanserski G; Neher JO
    Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
    [No Abstract]   [Full Text] [Related]  

  • 34. Functional recovery after ischemic stroke--a matter of age: data from the Austrian Stroke Unit Registry.
    Knoflach M; Matosevic B; Rücker M; Furtner M; Mair A; Wille G; Zangerle A; Werner P; Ferrari J; Schmidauer C; Seyfang L; Kiechl S; Willeit J;
    Neurology; 2012 Jan; 78(4):279-85. PubMed ID: 22238419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
    Chitravas N; Dewey HM; Nicol MB; Harding DL; Pearce DC; Thrift AG
    Neurology; 2007 May; 68(20):1687-93. PubMed ID: 17502550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stroke in young people].
    Díaz-Marín C; Matías-Guiu J
    Rev Neurol; 1996 Feb; 24(126):148-52. PubMed ID: 8714478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in risk factors, stroke subtypes and outcome. Nineteen-year data from the Sagrat Cor Hospital of Barcelona stroke registry.
    Arboix A; Cendrós V; Besa M; García-Eroles L; Oliveres M; Targa C; Balcells M; Comes E; Massons J
    Cerebrovasc Dis; 2008; 26(5):509-16. PubMed ID: 18810238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do all young ischemic stroke patients need long-term secondary preventive medication?
    Naess H; Waje-Andreassen U; Thomassen L; Nyland H; Myhr KM
    Neurology; 2005 Aug; 65(4):609-11. PubMed ID: 16116127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Celiac disease and ischemic stroke].
    El Moutawakil B; Chourkani N; Sibai M; Moutaouakil F; Rafai M; Bourezgui M; Slassi I
    Rev Neurol (Paris); 2009 Nov; 165(11):962-6. PubMed ID: 19144365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors of carotid stenosis in first-ever ischemic stroke in Taiwan: a hospital-based study.
    Chang CH; Chang YJ; Lee TH; Hsu KC; Ryu SJ
    Acta Neurol Taiwan; 2006 Dec; 15(4):237-43. PubMed ID: 17214086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.